tiprankstipranks
Teva and Sanofi (SNY) Jump amid Impressive Drug Results
PremiumMarket NewsTeva and Sanofi (SNY) Jump amid Impressive Drug Results
5d ago
Spyre Therapeutics weakness after Teva data a buying opportunity, says BTIG
Premium
The Fly
Spyre Therapeutics weakness after Teva data a buying opportunity, says BTIG
5d ago
Teva price target raised to $25 from $23 at BofA
Premium
The Fly
Teva price target raised to $25 from $23 at BofA
5d ago
Teva, Sanofi announce results from Phase 2b RELIEVE UCCD study
PremiumThe FlyTeva, Sanofi announce results from Phase 2b RELIEVE UCCD study
5d ago
Monte Rosa Therapeutics appoints Hughes to board of directors
Premium
The Fly
Monte Rosa Therapeutics appoints Hughes to board of directors
9d ago
Teva call volume above normal and directionally bullish
Premium
The Fly
Teva call volume above normal and directionally bullish
11d ago
Notable open interest changes for December 2nd
PremiumThe FlyNotable open interest changes for December 2nd
20d ago
Teva put volume heavy and directionally bearish
Premium
The Fly
Teva put volume heavy and directionally bearish
1M ago
Teva Pharmaceutical Strengthens Board with New Appointment
Premium
Company Announcements
Teva Pharmaceutical Strengthens Board with New Appointment
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100